Concord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...

Afcons Infrastructure shares surged following a significant contract win. The company will construct a 10.14-km breakwater for Vadhvan Port...

Dixon Technologies' shares rose after its subsidiary, Dixon Electroconnect, partnered with Gemtek Technology to form a joint venture. This ...

Brigade Enterprises has fixed June 17 as the record date for its 1:3 bonus share issue after receiving shareholder approval through an e-vo...

Infosys has set June 10 as the record date to determine shareholder eligibility for its final dividend of Rs 25 per share. Since shares mus...

India achieved a current account surplus of $7.1 billion in Q4 FY26, driven by robust services exports and remittances. Despite a growing m...

The State Bank of India (SBI) presented a dividend cheque of Rs 8,813 crore to the government for the financial year ending March 31, 2026....

Shares of Adani Ports saw an uptick on Friday after Goldman Sachs reaffirmed its ‘Buy’ rating and raised the target price to Rs 1,870. Stro...

Amit Khurana of Dolat Capital has upgraded India's IT sector, citing depressed valuations and rupee depreciation as key drivers. He believe...

UBS has downgraded BHEL to "Neutral" from "Buy", citing a more balanced risk-reward outlook after the stock's strong run, though it raised ...

Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...

Indian stock markets are cautious. The Nifty is losing support levels, indicating a bearish trend. Midcap and smallcap stocks are also seei...

Zee Entertainment shares rallied 20% over the past five trading sessions, hitting a nearly six-month high and adding more than Rs 1,660 cro...

JM Financial's shares plunged 8% following a significant drop in fourth-quarter net revenue and profit. While full-year profit after tax sa...

IndiGo's shares surged despite a Q4 FY26 net loss of Rs 2,536 crore, driven by Middle East conflict disruptions. Analysts remain largely po...

During January-March, the company's total income from operations also fell to Rs 1,305.50 crore from Rs 1,310.65 crore a year earlier.

Natco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...